Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The latest updates on our research and how it is improving people’s lives.

First UK spine fracture patients identified by NHS-X and Nanox.AI Artificial Intelligence research study

Main

The NHS ADOPT study has now begun to automatically identify patients with vertebral fracture, by using Nanox.AI an Artificial Intelligence (AI) programme to review thousands of hospital computed tomography (CT) scans. The patients are now being fast-tracked for bone health assessment by an NHS osteoporosis team.

NDORMS launches new translational unit to further critical research into multiple myeloma

Main

The Oxford Translational Myeloma Centre (OTMC) will be a collective force of research, outreach and patient care that will transform treatment opportunities for multiple myeloma cancer patients.

Daniele Cotton wins St Edmund Hall’s Ex Aula Prize

Main

Congratulations to Daniele Cotton winner of St Edmund Hall’s graduate research journal prize for his article ‘Jailbreak – Preventing Metastatic Cancer.’

How to build a cellular map of the musculoskeletal system

Main

A single-cell resolution atlas of the human musculoskeletal system could be transformative to understanding and treating conditions including arthritis, cancer and fractures.

New research endoscopy service launches today

Main

The launch of a new endoscopy service at the Oxford Experimental Medicine Clinical Research Facility (EMCRF) will enhance the collection of data for research projects at NDORMS and across the University of Oxford.

Psoriatic arthritis awareness day - a patients story

Main

The early warning signs of psoriatic arthritis (PsA) can be hard to spot. Any delay in diagnosis of PsA can leave patients uncomfortable and in pain. But slow diagnosis is all too common, according to Professor Laura Coates. She is leading a new study called HPOS, that is looking for 2000 UK volunteers to chart their psoriasis symptoms, and which may help to explain why one third of psoriasis patients to go on to develop arthritis.

New target identified for pancreatic cancer treatment

Main

Researchers at NDORMS have found a protein to block the growth of cancer stem-like cells as a possible treatment for pancreatic cancer.

James Fullerton awarded an Oxford-Bristol Myers Squibb Fellowship

Main

Three new Oxford-BMS Fellowships were announced across the Medical Sciences Division to support translational research projects.

New professors named at NDORMS

Main

Four NDORMS researchers have been honoured in the 2023 Recognition of Distinction Scheme, the University of Oxford’s annual exercise to confer the title of full professor for excellence in research and teaching.

Professor Chris Lavy named Honorary Fellow of the Royal College of Physicians and Surgeons of Glasgow

Main

NDORMS Professor of Orthopaedic and Tropical Surgery Chris Lavy has been made an Honorary Fellow of the Royal College of Physicians and Surgeons of Glasgow.

What frozen shoulder can teach us about knee arthrofibrosis

Main

Arthrofibrosis is the build-up of too much scar tissue (fibrosis) after an injury or surgery resulting in a stiffening of a joint and causing pain and disability. It’s common following knee replacement for osteoarthritis where 1 in 4 affected patients require additional surgery to correct the fibrosis and restore motion in the knee joint.

Fair safe medical AI: a South Asia case study to co-develop local agency & trust leaving no one behind

Main

The Planetary Health Informatics Lab led by Associate Professor Sara Khalid at NDORMS has announced that it is a winner of a Global Grand Challenges award – an initiative fostering innovation to solve pressing global health and development problems and funded by the Bill & Melinda Gates Foundation.

No link found between patient genetics and response to anti-IL17 therapy

Main

A new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient’s genetic variants and their response to therapy. This study challenges the idea that genetics might significantly account for the variable responses to anti-IL17 therapy seen in the clinic.

Bespoke 3D lab models could unlock the secret to soft tissue joint diseases

Main

Research into the onset and progression of diseases affecting musculoskeletal soft tissues could be greatly advanced using novel 3D models say NDORMS researchers in a review published in The Lancet Rheumatology.

Monkeypox vaccine team wins delivery award

Main

A collaborative team that responded to the monkeypox (Mpox) epidemic by rolling out a vaccination clinic in Oxford has received an award for delivery in the OUH Staff Recognition Awards.

Ageing beyond earth: Oxford opens the UK’s first Space Innovation Lab

Main

The UK’s first Space Innovation Lab, dedicated to understanding the effect of space microgravity on the ageing process, opens at the Botnar Institute today.

EPSRC fellowship awarded to Huw Colin-York

Main

Huw Colin-York has been awarded a fellowship from the Engineering and Physical Sciences Research Council (EPSRC) to develop synthetic biology tools to understand the immune response.

Newly discovered cells could be responsible for atherosclerosis complications

Main

A new type of macrophages recently identified in atherosclerotic lesions could provide a missing link in understanding the inflammatory origins of the common yet fatal condition.

Psoriasis study looking for volunteers

Main

Researchers at the University of Oxford are looking for 2000 volunteers with psoriasis to join their study. Their goal is to explore any links between the skin condition and the development of arthritis.

Antibiotic bone cement found not to reduce infection after hip replacement

Main

A large trial has found that using high-dose dual-antibiotic loaded cement is unlikely to reduce the risk of surgical site infection in people who have had a hip replacement.

Load More